Filing Flows

Filing Flows › Harvard Bioscience (HBIO) › Q1 2026 › vs Q4 2025

Harvard Bioscience (HBIO) Q1 2026 vs Q4 2025 (quarter over quarter)

Harvard Bioscience's revenue fell $3.0M (-13%) from $23.7M in Q4 2025 to $20.8M in Q1 2026. The biggest changes: Instruments, Equipment, Software, and Accessories −$3.1M (-14%); Service, Maintenance, and Warranty Contracts +$89K (+4%).

Harvard Bioscience, Q1 2026: revenue $20.8M (-5% year over year), operating margin -5.7%, net loss $3.4M, operating cash flow −$662K. The chart draws each line against Q4 2025, the increases inside each band.

Harvard Bioscience: what changed, Q1 2026 vs Q4 2025Harvard Bioscience: what changed, Q1 2026 vs Q4 2025Instruments, Equipment, Softw…−$3.1MInterest & other, net−$2.8MCosts & expenses−$2.8MCost of revenue−$1.1MGeneral & admin$583KNet loss$577KOperating cash sources$577KNet loss absorbed$577KCash used in operations$566KIncome tax$474K

Every line

LineQ1 2026Q4 2025Change%
Instruments, Equipment, Software, and Accessories$18.6M$21.6M−$3.1M-14%
Service, Maintenance, and Warranty Contracts$2.2M$2.1M$89K+4%
Revenue$20.8M$23.7M−$3.0M-13%
Net loss$3.4M$2.8M$577K+20%
Costs & expenses$24.2M$26.9M−$2.8M-10%
Operating costs$21.9M$22.0M−$96K-0.4%
Interest & other, net$2.1M$4.9M−$2.8M-57%
Income tax$117K−$357K$474K—
Cost of revenue$8.5M$9.6M−$1.1M-11%
Research & development$2.3M$2.2M$143K+7%
Sales & marketing$5.3M$5.1M$242K+5%
General & admin$4.7M$4.1M$583K+14%
Other operating costs$1.1M$1.1M−$12K-1%
Operating cash sources$3.4M$2.8M$577K+20%
Depreciation & amortization$1.3M$1.3M−$43K-3%
Share-based compensation$257K$459K−$202K-44%
Working capital & other$1.2M$986K$256K+26%
Cash used in operations$662K$96K$566K+590%
Net loss absorbed$3.4M$2.8M$577K+20%

Questions

How much did Harvard Bioscience's revenue grow quarter over quarter in Q1 2026?

Harvard Bioscience's revenue fell $3.0M (-13%) from $23.7M in Q4 2025 to $20.8M in Q1 2026.

What drove Harvard Bioscience's revenue change in Q1 2026?

Instruments, Equipment, Software, and Accessories −$3.1M (-14%); Service, Maintenance, and Warranty Contracts +$89K (+4%).

Q1 2026 results → · Compare in the interactive Sankey →